PMC:7534795 / 43772-43892 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T362","span":{"begin":67,"end":88},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"lacebo given to match sarilumab administration (NCT04315298, 2020)\n• CORIMUNO-SARI Trial\n• Sarilumab to mitigate enhance"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1332","span":{"begin":22,"end":31},"obj":"Chemical"}],"attributes":[{"id":"A1332","pred":"tao:has_database_id","subj":"1332","obj":"MESH:C000592401"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lacebo given to match sarilumab administration (NCT04315298, 2020)\n• CORIMUNO-SARI Trial\n• Sarilumab to mitigate enhance"}